Publication Name	World Journal of Gastrointestinal Endoscopy
Manuscript ID	69049
Country	United States

Received	2021-06-14 21:57
Peer-Review Started	2021-06-14 22:00
To Make the First Decision
Return for Revision	2021-07-27 06:07
Revised	2021-08-02 20:24
Second Decision	2022-01-21 05:46
Accepted by Journal Editor-in-Chief
Accepted by Company Editor-in-Chief	2022-01-23 03:50
Articles in Press	2022-01-23 03:50
Publication Fee Transferred
Edit the Manuscript by Language Editor
Typeset the Manuscript	2022-02-08 09:46
Publish the Manuscript Online	2022-02-10 07:37

ISSN	1948-5190 (online)
Open Access	This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/
Copyright	©The Author(s) 2022. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher	Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website	http://www.wjgnet.com

Category	Gastroenterology & Hepatology
Manuscript Type	Minireviews
Article Title	Endoscopic colorectal cancer surveillance in inflammatory bowel disease: Considerations that we must not forget
Manuscript Source	Invited Manuscript
All Author List	Paulina Núñez F, Rodrigo Quera and David T Rubin
ORCID	Author(s) ORCID Number Paulina Núñez F http://orcid.org/0000-0003-3727-1851 Rodrigo Quera http://orcid.org/0000-0001-5854-0526 David T Rubin http://orcid.org/0000-0001-5647-1723
Funding Agency and Grant Number
Corresponding Author	David T Rubin, AGAF, FACG, MD, Chief Doctor, Medicine Inflammatory Bowel Disease Center, University of Chicago , 5841 S. Maryland Ave., MC4076, Room M410, Chicago, IL 60637, United States. drubin@medicine.bsd.uchicago.edu
Key Words	Inflammatory bowel disease; Endoscopy; Crohn’s disease; Ulcerative colitis; Surveillance; Colorectal cancer
Core Tip	Colorectal cancer (CRC) is one of the leading causes of death in inflammatory bowel disease (IBD) today. However, subsequent reports have shown lower rates of CRC. The expanding medical options in IBD have substantially improved our ability to control severe inflammation and likely to reduce the risk of CRC in this setting. We discuss the current evidence of the risks of developing CRC, and evaluate the best available strategies for detection and surveillance, as well as future opportunities for cancer prevention.
Publish Date	2022-02-10 07:37
Citation	Núñez FP, Quera R, Rubin DT. Endoscopic colorectal cancer surveillance in inflammatory bowel disease: Considerations that we must not forget. World J Gastrointest Endosc 2022; 14(2): 85-95
URL	https://www.wjgnet.com/1948-5190/full/v14/i2/85.htm
DOI	https://dx.doi.org/10.4253/wjge.v14.i2.85

Full Article (PDF)	WJGE-14-85.pdf
Full Article (Word)	WJGE-14-85.docx
Manuscript File	69049_Auto_Edited.docx
Answering Reviewers	69049-Answering reviewers.pdf
Audio Core Tip	69049-Audio core tip.mp4
Conflict-of-Interest Disclosure Form	69049-Conflict-of-interest statement.pdf
Copyright License Agreement	69049-Copyright license agreement.pdf
Peer-review Report	69049-Peer-review(s).pdf
Scientific Misconduct Check	69049-Bing-Wang LL-2.png
Scientific Editor Work List	69049-Scientific editor work list.pdf